Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks". | Cell Mol Immunol | 2024 | 37985854 | PubTator, text mining | PubMed |
| The interplay of drug therapeutics and immune responses to SARS-CoV-2. | Cell Mol Immunol | 2024 | 37964122 | PubTator, text mining | PubMed |
| Veratramine inhibits porcine epidemic diarrhea virus entry through macropinocytosis by suppressing PI3K/Akt pathway. | Virus Res | 2024 | 37923169 | PubTator, text mining | PubMed |
| Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease. | bioRxiv | 2024 | 37502865 | PubTator, text mining | PubMed |
| Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches. | Mol Biotechnol | 2024 | 36752937 | PubTator, text mining | PubMed |
| Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response. | Front Chem | 2023 | 38293247 | PubTator, text mining | PubMed |
| Structural Basis for the Inhibition of SARS-CoV-2 Mpro D48N Mutant by Shikonin and PF-07321332. | Viruses | 2023 | 38257765 | PubTator, text mining | PubMed |
| Zoonosis and zooanthroponosis of emerging respiratory viruses. | Front Cell Infect Microbiol | 2023 | 38249300 | PubTator, text mining | PubMed |
| A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety. | Infect Med (Beijing) | 2023 | 38205179 | PubTator, text mining | PubMed |
| Genetic diversity and evolutionary patterns of SARS-CoV-2 among the Bhutanese population during the pandemic. | Osong Public Health Res Perspect | 2023 | 38204428 | PubTator, text mining | PubMed |
| Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications. | Ther Adv Endocrinol Metab | 2023 | 38152659 | PubTator, text mining | PubMed |
| Signaling plasticity in the integrated stress response. | Front Cell Dev Biol | 2023 | 38143923 | PubTator, text mining | PubMed |
| Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. | Viruses | 2023 | 38140532 | PubTator, text mining | PubMed |
| De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design. | Int J Mol Sci | 2023 | 38139312 | PubTator, text mining | PubMed |
| TIMAP, a Regulatory Subunit of Protein Phosphatase 1, Inhibits In Vitro Neuronal Differentiation. | Int J Mol Sci | 2023 | 38139189 | PubTator, text mining | PubMed |
| The PPP1R15 Family of eIF2-alpha Phosphatase Targeting Subunits (GADD34 and CReP). | Int J Mol Sci | 2023 | 38139150 | PubTator, text mining | PubMed |
| Antiviral activity of chrysin and naringenin against porcine epidemic diarrhea virus infection. | Front Vet Sci | 2023 | 38130439 | PubTator, text mining | PubMed |
| Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16. | Elife | 2023 | 38127066 | PubTator, text mining | PubMed |
| Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin. | Extracell Vesicles Circ Nucl Acids | 2023 | 38125374 | PubTator, text mining | PubMed |
| The effect of quercetin supplementation on clinical outcomes in COVID-19 patients: A systematic review and meta-analysis. | Food Sci Nutr | 2023 | 38107099 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=6